NCT01586507View on ClinicalTrials.gov

A Study of ULTRAM ER at Two Dose Levels in Adolescents With Pain

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Pain
Interventions
DRUG

ULTRAM ER

One dose of ULTRAM ER that is closest to 2 mg/kg, based on the participant's body weight and adjusting the dose in 25 mg increments.

DRUG

ULTRAM ER

The target dose for Group 2 will be the one that achieves a level of exposure similar to that seen with a single 200 mg ULTRAM ER dose in adults.

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT01586507 - A Study of ULTRAM ER at Two Dose Levels in Adolescents With Pain | Biotech Hunter | Biotech Hunter